{"id":97859,"date":"2024-12-13T13:04:31","date_gmt":"2024-12-13T21:04:31","guid":{"rendered":"https:\/\/xira.com\/p\/2024\/12\/13\/litigation-surge-drugmakers-launch-flood-of-suits-to-halt-generics\/"},"modified":"2024-12-13T13:04:31","modified_gmt":"2024-12-13T21:04:31","slug":"litigation-surge-drugmakers-launch-flood-of-suits-to-halt-generics","status":"publish","type":"post","link":"https:\/\/xira.com\/p\/2024\/12\/13\/litigation-surge-drugmakers-launch-flood-of-suits-to-halt-generics\/","title":{"rendered":"Litigation Surge: Drugmakers Launch Flood of Suits to Halt Generics"},"content":{"rendered":"<p>At least 29 patent suits were filed in the District of New Jersey in November, reflecting a jump from the rate of 18 suits per month in the period from December 2023 to November 2024. The multitude of suits include many that stem from generic drugmakers&#8217; plans to sell lower-priced versions of recognized pharmaceutical products.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" align=\"left\" border=\"0\" height=\"1\" width=\"1\" alt=\"\" hspace=\"0\" src=\"https:\/\/feeds.feedblitz.com\/~\/i\/909349478\/0\/law\/legal-news\" title=\"\"><\/p>\n<div><a href=\"https:\/\/feeds.feedblitz.com\/_\/2\/909349478\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/fbshare20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/28\/909349478\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/fblike20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/29\/909349478\/law\/legal-news,\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/pinterest20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/12\/909349478\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/stumble20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/24\/909349478\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/x.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/20\/909349478\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/rss20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0\u00a0<\/div>\n<p>At least 29 patent suits were filed in the District of New Jersey in November, reflecting a jump from the rate of 18 suits per month in the period from December 2023 to November 2024. The multitude of suits include many that stem from generic drugmakers&#8217; plans to sell lower-priced versions of recognized pharmaceutical products.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" align=\"left\" border=\"0\" height=\"1\" width=\"1\" alt=\"\" hspace=\"0\" src=\"https:\/\/feeds.feedblitz.com\/~\/i\/909349478\/0\/law\/legal-news\" title=\"\"><\/p>\n<div><a href=\"https:\/\/feeds.feedblitz.com\/_\/2\/909349478\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/fbshare20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/28\/909349478\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/fblike20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/29\/909349478\/law\/legal-news,\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/pinterest20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/12\/909349478\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/stumble20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/24\/909349478\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/x.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/20\/909349478\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/rss20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0\u00a0<\/div>\n","protected":false},"excerpt":{"rendered":"<p>At least 29 patent suits were filed in the District of New Jersey in November, reflecting a jump from the rate of 18 suits per month in the period from December 2023 to November 2024. The multitude of suits include many that stem from generic drugmakers&#8217; plans to sell lower-priced versions of recognized pharmaceutical products. [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":97860,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[23,17],"tags":[],"class_list":["post-97859","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-com","category-legal_matters"],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/xira.com\/p\/wp-content\/uploads\/2024\/12\/legal-news-DOyqpV.jpeg?fit=767%2C633&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts\/97859","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/comments?post=97859"}],"version-history":[{"count":0,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts\/97859\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/media\/97860"}],"wp:attachment":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/media?parent=97859"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/categories?post=97859"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/tags?post=97859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}